Effect of VGLUT inhibitors on glutamatergic synaptic transmission in the rodent hippocampus and prefrontal cortex

Neurochemistry International

Volumn 73, Issue 1, 2014, Pages 159-165

  Neale, S A ^a,b   Copeland, C S ^b   Salt, T E ^b  

^a Neurexpert Ltd   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Glutamate; Presynaptic; Schizophrenia; Synaptic; Transporter; VGLUT

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; CHICAGO SKY BLUE 6B; CONGO RED; GLUTAMIC ACID; KYNURENINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN INHIBITOR; ROSE BENGAL; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER; VESICULAR GLUTAMATE TRANSPORTER INHIBITOR; XANTHURENIC ACID; 2 AMINO 5 PHOSPHONOVALERIC ACID; 2,3-DIOXO-6-NITRO-7-SULFAMOYLBENZO(F)QUINOXALINE; AMINO ACID RECEPTOR BLOCKING AGENT; GLUTAMATE TRANSPORTER; QUINOXALINE DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; IN VITRO STUDY; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; VENTROMEDIAL PREFRONTAL CORTEX; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DRUG EFFECTS; PHYSIOLOGY; PREFRONTAL CORTEX;

RODENTIA;

2-AMINO-5-PHOSPHONOVALERATE; AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; CA1 REGION, HIPPOCAMPAL; DENTATE GYRUS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLUTAMIC ACID; HIPPOCAMPUS; MICE; MICE, INBRED C57BL; PREFRONTAL CORTEX; QUINOXALINES; SYNAPTIC TRANSMISSION;

EID: 84902468525     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.10.001     Document Type: Article

References (51)

1. S.K. Ahmed, J.L. Etoga, S.A. Patel, R.J. Bridges, and C.M. Thompson Use of the hydantoin isostere to produce inhibitors showing selectivity toward the vesicular glutamate transporter versus the obligate exchange transporter system x(c)(-) Bioorg. Med. Chem. Lett. 21 2011 4358 4362
2. P. Anderson, R. Morris, D. Amaral, T. Bliss, and J. O'Keefe The Hippocampus Book 2007 Oxford University Press
3. D. Balschun, D. Moechars, Z. Callaerts-Vegh, B. Vermaercke, A.N. Van, and L. Andries et al. Vesicular glutamate transporter VGLUT1 has a role in hippocampal long-term potentiation. and spatial reversal learning Cereb. Cortex 20 2010 684 693
4. R.D. Bartlett, C.S. Esslinger, C.M. Thompson, and R.J. Bridges Substituted quinolines as inhibitors of l-glutamate transport into synaptic vesicles Neuropharmacology 37 1998 839 846
5. E.E. Bellocchio, R.J. Reimer, R.T. Fremeau Jr., and R.H. Edwards Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter Science 289 2000 957 960
6. C.A. Benassi, P. Benassi, G. Allegri, and P. Ballarin Tryptophan metabolism in schizophrenic patients J. Neurochem. 7 1961 264 270
7. A.J. Berger, S. Dieudonne, and P. Ascher Glycine uptake governs glycine site occupancy at NMDA receptors of excitatory synapses J. Neurophysiol. 80 1998 3336 3340
8. C.N. Carrigan, R.D. Bartlett, C.S. Esslinger, K.A. Cybulski, P. Tongcharoensirikul, and R.J. Bridges et al. Synthesis and in vitro pharmacology of substituted quinoline-2,4-dicarboxylic acids as inhibitors of vesicular glutamate transport J. Med. Chem. 45 2002 2260 2276
9. S.L. Eastwood, and P.J. Harrison Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons Schizophr. Res. 73 2005 159 172
10. J.L. Etoga, S.K. Ahmed, S. Patel, R.J. Bridges, and C.M. Thompson Conformationally-restricted amino acid analogues bearing a distal sulfonic acid show selective inhibition of system x(c)(-) over the vesicular glutamate transporter Bioorg. Med. Chem. Lett. 20 2010 2680 2683
11. R.T. Fremeau Jr., K. Kam, T. Qureshi, J. Johnson, D.R. Copenhagen, and J. Storm-Mathisen et al. Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites Science 304 2004 1815 1819
12. R.T. Fremeau Jr., M.D. Troyer, I. Pahner, G.O. Nygaard, C.H. Tran, and R.J. Reimer et al. The expression of vesicular glutamate transporters defines two classes of excitatory synapse Neuron 31 2001 247 260
13. P. Frid, S.V. Anisimov, and N. Popovic Congo red and protein aggregation in neurodegenerative diseases Brain Res. Rev. 53 2007 135 160
14. F. Fujiyama, T. Furuta, and T. Kaneko Immunocytochemical localization of candidates for vesicular glutamate transporters in the rat cerebral cortex J. Comp. Neurol. 435 2001 379 387
15. S. Gobaille, V. Kemmel, D. Brumaru, C. Dugave, D. Aunis, and M. Maitre Xanthurenic acid distribution, transport, accumulation and release in the rat brain J. Neurochem. 105 2008 982 993
16. Z. He, L. Yan, Z. Yong, Z. Dong, H. Dong, and Z. Gong Chicago sky blue 6B, a vesicular glutamate transporters inhibitor, attenuates methamphetamine-induced hyperactivity and behavioral sensitization in mice Behav. Brain Res. 239 2013 172 176
17. M.A. Herman, and C.E. Jahr Extracellular glutamate concentration in hippocampal slice J. Neurosci. 27 2007 9736 9741
18. E. Herzog, S. Takamori, R. Jahn, N. Brose, and S.M. Wojcik Synaptic and vesicular co-localization of the glutamate transporters VGLUT1 and VGLUT2 in the mouse hippocampus J. Neurochem. 99 2006 1011 1018
19. M.J. Higley, A.H. Gittis, I.A. Oldenburg, N. Balthasar, R.P. Seal, and R.H. Edwards et al. Cholinergic interneurons mediate fast VGluT3-dependent glutamatergic transmission in the striatum PLoS One 6 2011 e19155
20. N. Juge, J.A. Gray, H. Omote, T. Miyaji, T. Inoue, and C. Hara et al. Metabolic control of vesicular glutamate transport and release Neuron 68 2010 99 112
21. 2+ and short-term synaptic plasticity Nature 371 1994 603 606
22. B.U. Keller, M. Blaschke, R. Rivosecchi, M. Hollmann, S.F. Heinemann, and A. Konnerth Identification of a subunit-specific antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate/kainate receptor channels Proc. Natl. Acad. Sci. USA 90 1993 605 609
23. J.N. Kew, M.C. Pflimlin, J.A. Kemp, and V. Mutel Differential regulation of synaptic transmission by mGlu2 and mGlu3 at the perforant path inputs to the dentate gyrus and CA1 revealed in mGlu2 -/- mice Neuropharmacology 43 2002 215 221
24. T.A. Macek, D.G. Winder, R.W. Gereau, C.O. Ladd, and P.J. Conn Differential involvement of group II and group III mGluRs as autoreceptors at lateral and medial perforant path synapses J. Neurophysiol. 76 1996 3798 3806
25. D. Moechars, M.C. Weston, S. Leo, Z. Callaerts-Vegh, I. Goris, and G. Daneels et al. Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain J. Neurosci. 26 2006 12055 12066
26. J.A. Monn, M.J. Valli, S.M. Massey, R.A. Wright, C.R. Salhoff, and B.G. Johnson et al. Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties J. Med. Chem. 40 1997 528 537
27. J.A. Morrow, R. Gilfillan, and S.A. Neale Glutamatergic approaches for the treatment of schizophrenia Z. Rankovic, R. Hargreaves, M. Bingham, Drug Discovery for Psychiatric Disorders 2012 RSC Publishing 56 98
28. A.M. Myint Kynurenines: from the perspective of major psychiatric disorders FEBS J. 279 2012 1375 1385
29. S.A. Neale, C.S. Copeland, V.N. Uebele, F.J. Thomson, and T.E. Salt Modulation of hippocampal synaptic transmission by the Kynurenine pathway member Xanthurenic acid and other VGLUT inhibitors Neuropsychopharmacology 38 2013 1060 1067
30. S.A. Neale, and T.E. Salt Modulation of GABAergic inhibition in the rat superior colliculus by a presynaptic group II metabotropic glutamate receptor J. Physiol. 577 2006 659 669
31. B. Ni, P.R. Rosteck Jr., N.S. Nadi, and S.M. Paul Cloning and expression of a cDNA encoding a brain-specific Na(+)-dependent inorganic phosphate cotransporter Proc. Natl. Acad. Sci. USA 91 1994 5607 5611
32. K. Ogita, K. Hirata, D.G. Bole, S. Yoshida, Y. Tamura, and A.M. Leckenby et al. Inhibition of vesicular glutamate storage and exocytotic release by Rose Bengal J. Neurochem. 77 2001 34 42
33. A. Oni-Orisan, L.V. Kristiansen, V. Haroutunian, J.H. Meador-Woodruff, and R.E. McCullumsmith Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia Biol. Psychiatry 63 2008 766 775
34. N. Pietrancosta, A. Kessler, F.C. Favre-Besse, N. Triballeau, T. Quentin, and B. Giros et al. Rose Bengal analogs and vesicular glutamate transporters (VGLUTs) Bioorg. Med. Chem. 18 2010 6922 6933
35. C.J. Price, and L.A. Raymond Evans blue antagonizes both alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate and kainate receptors and modulates receptor desensitization Mol. Pharmacol. 50 1996 1665 1671
36. J. Price, R. Brown, and H. Peters Tryptophan metabolism in porphyria, schizophrenia, and a variety of neurologic and psychiatric diseases Neurology 9 1959 456 468
37. A. Schallier, A. Massie, E. Loyens, D. Moechars, W. Drinkenburg, and Y. Michotte et al. VGLUT2 heterozygous mice show more susceptibility to clonic seizures induced by pentylenetetrazol Neurochem. Int. 55 2009 41 44
38. R. Schwarcz, J.P. Bruno, P.J. Muchowski, and H.Q. Wu Kynurenines in the mammalian brain: when physiology meets pathology Nat. Rev. Neurosci. 13 2012 465 477
39. R.P. Seal, O. Akil, E. Yi, C.M. Weber, L. Grant, and J. Yoo et al. Sensorineural deafness and seizures in mice lacking vesicular glutamate transporter 3 Neuron 57 2008 263 275
40. R.P. Seal, X. Wang, Y. Guan, S.N. Raja, C.J. Woodbury, and A.I. Basbaum et al. Injury-induced mechanical hypersensitivity requires C-low threshold mechanoreceptors Nature 462 2009 651 655
41. M.J. Sheardown, E.O. Nielsen, A.J. Hansen, P. Jacobsen, and T. Honore 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia Science 247 1990 571 574
42. Y. Shigeri, R.P. Seal, and K. Shimamoto Molecular pharmacology of glutamate transporters, EAATs and VGLUTs Brain Res. Brain Res. Rev. 45 2004 250 265
43. L. Siksou, K. Silm, C. Biesemann, R.B. Nehring, S.M. Wojcik, and A. Triller et al. A role for vesicular glutamate transporter 1 in synaptic vesicle clustering and mobility Eur. J. Neurosci 2013
44. M.C. Smear, H.W. Tao, W. Staub, M.B. Orger, N.J. Gosse, and Y. Liu et al. Vesicular glutamate transport at a central synapse limits the acuity of visual perception in zebrafish Neuron 53 2007 65 77
45. T.C. Sudhof The synaptic vesicle cycle: a cascade of protein-protein Interactions 375 1995 645 653
46. S. Takamori VGLUTs: 'exciting' times for glutamatergic research? Neurosci. Res. 55 2006 343 351
47. S. Takamori, J.S. Rhee, C. Rosenmund, and R. Jahn Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons Nature 407 2000 189 194
48. C.M. Thompson, E. Davis, C.N. Carrigan, H.D. Cox, R.J. Bridges, and J.M. Gerdes Inhibitor of the glutamate vesicular transporter (VGLUT) Curr. Med. Chem. 12 2005 2041 2056
49. A. Uezato, J.H. Meador-Woodruff, and R.E. McCullumsmith Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia Bipolar Disord. 11 2009 711 725
50. E. Varea, R. Guirado, J. Gilabert-Juan, U. Marti, E. Castillo-Gomez, and J.M. Blasco-Ibanez et al. Expression of PSA-NCAM and synaptic proteins in the amygdala of psychiatric disorder patients J. Psychiatr. Res. 46 2012 189 197
51. S.M. Wojcik, J.S. Rhee, E. Herzog, A. Sigler, R. Jahn, and S. Takamori et al. An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size Proc. Natl. Acad. Sci. USA 101 2004 7158 7163